Physician profile
Narendra Singh
NPI 1801819354
$2,018.61
in general payments reported to CMS, 2019-2025
21 companies · $715 in 2025
The $715 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.91 · 2020: $51.70 · 2021: $130 · 2022: $306 · 2023: $222 · 2024: $495 · 2025: $715.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,420.75 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $573.85 | 2019-2025 | Nucala, Trelegy Ellipta |
| Regeneron Healthcare Solutions, INC. | $343.44 | 2021-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $215.27 | 2019-2025 | Zerbaxa |
| Genzyme Corporation | $122.81 | 2021-2024 | |
| Grifols USA, LLC | $102.12 | 2022-2025 | Prolastin-C Liquid |
| Abbvie INC. | $85.61 | 2022-2025 | Avycaz |
| Zoll Respicardia, INC. | $80.72 | 2024 | Remede System |
| Baxter Healthcare | $80.01 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.16 | 2023-2025 | Ofev, Jascayd |
| Insmed, INC. | $55.61 | 2024-2025 | Arikayce |
| Astrazeneca Pharmaceuticals LP | $53.69 | 2024-2025 | Airsupra |
| Electromed, INC. | $46.14 | 2019-2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $32.56 | 2024 | |
| Inspire Medical Systems, INC. | $32.06 | 2025 | Inspire |
| Amgen INC. | $25.37 | 2025 | Tezspire |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $24.97 | 2020 | |
| Resmed Corp | $17.89 | 2025 | |
| Inogen, INC. | $16.41 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Advanced Respiratory, INC | $15.32 | 2019 | |
| Pfizer INC. | $15.29 | 2023 | |
| Genentech USA, INC. | $14.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narendra Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.